You are here

Mark Brager
June 8, 2016

Patient Access to Vital Medical Technology Highlighted at House Ways & Means Health Subcommittee Member Day

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on today’s Member Day Hearing of the House Ways and Means Committee Health Subcommittee:

“AdvaMed would like to commend members of the Ways and Means Health Subcommittee for highlighting bipartisan legislation which will improve the health and well-being of American patients and help provide them better access to needed medical advancements.

“Specifically, I would like to thank:

  • “Rep. Charles Boustany (R-La.) for his leadership on the Ensuring Patient Access to Critical Breakthrough Products Act (HR 5009), which would eliminate coverage and reimbursement delays at CMS that deny Medicare patients the opportunity to benefit from breakthrough medical technologies deemed safe and effective by FDA; and
  • “Rep. Tom Price (R-Ga.), who introduced the Patient Access to Durable Medical Equipment Act (HR 5210). This bill would delay upcoming cuts to durable medical equipment (DME) payment rates when CMS expands its competitive bidding program, preserving the availability of medical equipment vital to maintaining and improving the health and quality of life for millions of Medicare patients.

“Passing these bills would do so much to ensure that American patients continue to benefit from the life-changing innovations that AdvaMed member companies are producing every day. We look forward to working with Congress, the administration, patient and physician groups, and all other stakeholders to move these bills towards passage.”

# # #